fully-owned subsidiary ProBiotix Health has signed a non-exclusive license agreement with Tenshindo to use Lactobacillus plantarum, or LPLDL®, in cardiovascular food supplements in Japan.
LPLDL® is set to be the active ingredient in Tenshindo’s cardiovascular health product.
The Japanese partnership opens up a new market for the life sciences company as it continues to focus on compounds designed to tackle obesity, cardiovascular disease and diabetes.
It also represents the first end product application deal that has emerged from ProBiotix’s agreement with Japanese distributor EIWA Trading Corporation, signed earlier this year, to distribute LPLDL® in the country.
Dr. Luis Gosalbez, Business Development Director of OptiBiotix, commented: "We are pleased to announce this deal with Tenshindo, which will mean our first LPLDL® finished product placement on the Japanese market.
Obtaining an authorised cardiovascular health claim for LPLDL® from Japanese authorities will not only be highly advantageous from the commercial point of view, but also an important endorsement for ProBiotix's science. Tenshindo, with over 30 years of experience in this market, are an excellent commercial and regulatory partner to make the most of this opportunity."
For more news and updates on OptiBiotix Health:
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
The UK intellectual property investment group believes this particular partnership will flourish, in part, thanks to UTEQ’s prime location in the “high-tech zone” of Queretaro, cultivating the region’s technology and innovation scene.
SP Angel research note on commodities and miners, featuring: Condor Gold (CNR LN) – Progress report on permitting IronRidge Resources* (IRR LN) – Zaranou license high-grade gold Petropavlovsk (POG LN) – H1 2019 production results Shanta Gold (SHG LN) – Ilunga underground mine achieved commercial production
BP is to expand its Brazilian biofuels business by combining it with a larger rival in a move that it said would help the transition to lower-carbon energy, British Airways is launching legal action to block its pilots from staging a potentially disruptive walkout this summer
The company shared that approximately 67% of these revenues were derived from recurring contracts, especially the “transformational” acquisition of PeopleFluent back in May 2018.
SP Angel research note on commodities and miners, featuring: Galantas Gold (GAL LN) – Kearney Vein intersected on 1060 level of the Omagh mine Petra Diamonds (PDL LN) – Meets production guidance for year to 30th June Serabi Gold (SRB LN) – Production guidance maintained following Q2 results Tri-Star Resources* (TSTR LN) – SPMP report first antimony metal production